The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Will Be The Estimated Market Size Of The Contract Research And Manufacturing Services (CRAMS) Market By 2030?
The contract research and manufacturing services (crams) market size has seen rapid expansion in recent years. It will grow from $155.61 billion in 2025 to $171.86 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth observed in the past can be attributed to several factors, including rising r&d costs in the pharmaceutical sector, increasing demand for innovative drugs, limited in-house manufacturing capabilities, growing regulatory complexities, and the emergence of biotechnology companies.
The contract research and manufacturing services (crams) market is projected to experience swift expansion over the coming years, reaching a valuation of $258.36 billion by 2030, driven by a robust compound annual growth rate (CAGR) of 10.7%. This anticipated growth is primarily fueled by factors such as the rising acceptance of biologics and advanced therapies, an increase in outsourced clinical trials, the expanding need for personalized medicine, innovations in manufacturing automation technology, and the growing prevalence of contract manufacturing for medical devices. Key trends anticipated during this period encompass the outsourcing of pharmaceutical research and development, an expansion of services for biologics manufacturing, a heightened demand for analytical testing and quality control, the proliferation of custom synthesis and production services, and continued growth in the adoption of contract manufacturing for medical devices.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6041&type=smp
Which Growth Factors Are Strengthening The Contract Research And Manufacturing Services (CRAMS) Market Landscape?
The increasing elderly population, often afflicted with various chronic conditions, is expected to positively influence the expansion of the contract research and manufacturing services (CRAMS) market over the forecast period. The global ageing population is experiencing rapid growth and is anticipated to continue this trend throughout the forecast period. As the geriatric population grows, the prevalence of diseases such as cancer, diabetes, Alzheimer’s, arthritis, and other illnesses will also rise, leading to increased demand for various drugs or medicines. As a result, the necessity for contract research and manufacturing services will escalate. For instance, in September 2023, according to the Australian Bureau of Statistics, an Australia-based statistical agency, Australia’s population, which was 26 million in 2022, is projected to grow to between 34.3 million and 45.9 million by 2071. Additionally, the median age, currently 38.5 years, is forecast to increase to between 43.8 and 47.6 years. Consequently, the rising ageing population will stimulate the growth of the contract research and manufacturing services (CRAMS) market.
How Is The Contract Research And Manufacturing Services (CRAMS) Market Distributed Across Key Segments?
The contract research and manufacturing services (crams) market covered in this report is segmented –
1) By Services: Manufacturing, Research
2) By End User: Pharmaceutical And Biotechnology Companies, Medical Device Companies, Academic Institutes
3) By Product: API (Active Pharmaceutical Ingredient) Services, Finished Dosage Form (FDF) Services, Biologics / Cell & Gene Therapy Services, Formulation Development & Packaging
Subsegments:
1) By Manufacturing: Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Form (FDF) Manufacturing, Biologics Manufacturing, Contract Manufacturing Of Medical Devices, Formulation Development And Manufacturing, Packaging And Labeling Services, Analytical Testing And Quality Control, Custom Synthesis And Production
2) By Research: Preclinical Research, Clinical Research (Phase I-IV), Drug Discovery And Development Services, Regulatory Affairs And Consulting, Bioanalytical Testing Services, Toxicology Testing, Process Development And Optimization, Clinical Trial Management And Monitoring, Pharmacovigilance And Safety Services
Which Trends Are Influencing The Expansion Of The Contract Research And Manufacturing Services (CRAMS) Market?
The contract research and manufacturing services (CRAMS) market is increasingly utilizing artificial intelligence (AI) to enhance its market standing. Artificial intelligence is a field of computer science that deals with the replication of human behavior in machines. AI can help prevent expensive maintenance by forecasting when it is required and supports the healthcare system. For example, in June 2024, Medidata, a US-based technology company, unveiled the Medidata clinical data studio, which focuses on integrating and overseeing clinical trial data from various sources to improve the efficiency and accuracy of clinical research. It leverages artificial intelligence to simplify data review and reconciliation, allowing study teams to more effectively identify potential data issues and safety signals. The platform provides an extensive workspace for data integration, transformation, and management, enabling users to adopt robust risk-based quality management strategies and access insights in real time.
Who Are The Businesses Driving Activity In The Contract Research And Manufacturing Services (CRAMS) Market?
Major companies operating in the contract research and manufacturing services (crams) market are Lonza Group, Catalent Inc., WuXi AppTec, Boehringer Ingelheim, Charles River Laboratories, Jubilant Life Sciences, PRA Health Sciences, Syngene International Ltd., Samsung Biologics, Evotec AG, AMRI (Albany Molecular Research Inc.), Parexel International Corporation, ICON plc, IQVIA Holdings Inc., PPD (Pharmaceutical Product Development), Recipharm AB, Curia Global Inc., Cambrex Corporation, Labcorp Drug Development, CordenPharma, Medpace Holdings Inc., FAMAR Health Care Services, Rentschler Biopharma SE, PCI Pharma Services, Dishman Carbogen Amcis Ltd., Thermo Fisher Scientific Inc., ProPharma Group, Siegfried AG
Access The Complete Contract Research And Manufacturing Services (CRAMS) Market Report:
Which Region Has The Strongest Presence In The Contract Research And Manufacturing Services (CRAMS) Market?
North America was the largest region in the contract research and manufacturing services (CRAMS) market in 2025. Asia-Pacific region is expected to grow at a faster pace in the forecast period. The regions covered in the contract research and manufacturing services (crams) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Contract Research And Manufacturing Services (CRAMS) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=6041&type=smp
Browse Through More Reports Similar to the Global Contract Research And Manufacturing Services (CRAMS) Market 2026, By The Business Research Company
Contract Research And Manufacturing Services Market Report 2026
Contract Development Manufacturing Organizations Market Report 2026
Electronic Contract Manufacturing And Design Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model